Small molecule inhibition of proteasome and aggresome function induces synergistic anti-tumor activity in multiple myeloma.

被引：0
|
作者：
Hideshima, T
Bradner, JE
Wong, J
Chauhan, D
Richardson, PG
Schreiber, SL
Anderson, KC
机构：
[1] Dana Farber Canc Inst, Boston, MA USA
[2] Harvard Univ, Med Sch, Boston, MA USA
[3] Harvard Univ, Broad Inst, Cambridge, MA USA
[4] MIT, Cambridge, MA USA
[5] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1570
引用
收藏
页码：450A / 451A
页数：2
相关论文
共 50 条
  • [31] SH-4-54, a novel small-molecule inhibitor of STAT3, demonstrates significant anti-tumor activity against multiple myeloma
    Li, Zhi Hua
    Haftchenary, Sina
    Croucher, Danielle
    Gunning, Patrick T.
    Trudel, Suzanne
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [32] Targeting EZH2 in Multiple Myeloma-Multifaceted Anti-Tumor Activity
    Alzrigat, Mohammad
    Jernberg-Wiklund, Helena
    Licht, Jonathan D.
    EPIGENOMES, 2018, 2 (03)
  • [33] Mir-29a Displays in Vitro and in Vivo Anti-Tumor Activity in Multiple Myeloma
    Saha, Manujendra N.
    Chen, Yan
    Abdi, Jahangir
    Chang, Hong
    BLOOD, 2014, 124 (21)
  • [34] Biological pathways and in vivo anti-tumor activity induced by atiprimod in multiple myeloma (MM).
    Neri, Paola
    Tassone, Pierfrancesco
    Shammas, Masood
    Yasui, Hiroshi
    Schipani, Ernestina
    Batchu, Ramesh B.
    Blotta, Simona
    Prabhala, Rao
    Catley, Laurence
    Hamasaki, Makoto
    Hideshima, Teru
    Chauhan, Dharminder
    Jacob, Gary S.
    Picker, Donald
    Venuta, Salvatore
    Anderson, Kenneth C.
    Munshi, Nilchil C.
    BLOOD, 2006, 108 (11) : 986A - 986A
  • [35] Novel Targeting Of Phospho-Marcks Overcomes Drug Resistance and Induces Anti-Tumor Activity In Preclinical Models Of Multiple Myeloma
    Yang, Yijun
    Saha, Manujendra N.
    Chen, Yan
    Qiu, Lugui
    Reece, Donna E.
    Chang, Hong
    BLOOD, 2013, 122 (21)
  • [36] Anti-tumor activity of lysophosphatidic acid acyltransferase (LPAAT)-β inhibitors in multiple myeloma (MM).
    Hideshima, T
    Chauhan, D
    Hayashi, T
    Podar, K
    Akiyama, M
    Mitsiades, C
    Mitsiades, N
    Gong, BQ
    Bonham, L
    de Vries, P
    Munshi, NC
    Richardson, PG
    Singer, JW
    Anderson, KC
    BLOOD, 2003, 102 (11) : 451A - 452A
  • [37] Small Molecule Inhibition of SIRT Activity: A Novel Therapeutic Approach for Refractory Multiple Myeloma
    Nawrocki, Steffan T.
    Espitia, Claudia M.
    Visconte, Valeria
    Han, Yingchun
    Kelly, Kevin R.
    Carew, Jennifer S.
    BLOOD, 2015, 126 (23)
  • [38] Broad Anti-tumor Activity of a Small Molecule that Selectively Targets the Warburg Effect and Lipogenesis
    Flaveny, Colin A.
    Griffett, Kristine
    El-Gendy, Bahaa El-Dien M.
    Kazantzis, Melissa
    Sengupta, Monideepa
    Amelio, Antonio L.
    Chatterjee, Arindam
    Walker, John
    Solt, Laura A.
    Kamenecka, Theodore M.
    Burris, Thomas P.
    CANCER CELL, 2015, 28 (01) : 42 - 56
  • [39] Anti-tumor activity of novel small molecule inhibitors of mixed protein kinases.
    Narla, RK
    Stein, B
    Ezell, C
    Mortensen, D
    Raymon, HK
    Gamez, J
    Sapienza, J
    Wright, J
    Hughes, K
    Fultz, K
    Delgado, M
    Boluro-Ajayi, M
    Shirley, MA
    Khatsenko, O
    Pai, S
    Clareen, S
    Bhagwat, S
    Sakata, S
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6243S - 6243S
  • [40] Small Molecule Inhibition of MAGE-A3 Induces Cell Cycle Arrest and Apoptosis in Multiple Myeloma
    Mei, Anna Huo Chang
    Kaniskan, Husnu
    Park, Kwang-su
    Jin, Jian
    Osman, Roman
    Cho, Hearn Jay
    BLOOD, 2023, 142
12345